Introduction
In the treatment of acute large-vessel occlusion (LVO) strokes, the mantra "Time is Brain" underscores the critical need for rapid reperfusion. While mechanical thrombectomy has revolutionized care, clinicians often debate whether the benefits of speed diminish in elderly populations due to reduced physiological resilience or poorer baseline prognoses. This subanalysis of the RESCUE-Japan Registry 2 investigates the relationship between onset-to-reperfusion time (ORT) and functional outcomes across different age brackets.
Methods
The study utilized data from the RESCUE-Japan Registry 2, a multicenter, nationwide prospective registry tracking real-world outcomes for LVO patients undergoing endovascular treatment. Patients were categorized into three age subgroups: <70 years, 70 to <80 years, and ≥80 years. Onset-to-reperfusion time (ORT) was divided into four intervals: <180, 180–240, 240–300, and ≥300 minutes. The primary outcome was a "good outcome," defined as functional independence (modified Rankin Scale score ≤2) at 90 days. Adjusted odds ratios (AOR) were calculated to account for potential confounders.
Results
The analysis revealed a consistent downward trend in the probability of a good outcome as ORT increased, regardless of patient age.
As shown in the bar charts, younger patients (<70 years) experienced the most dramatic benefit from early intervention, with a 91% success rate when treated within 3 hours, dropping to 53% after 5 hours. In the oldest group (≥80 years), the success rate was lower overall but still showed a decline from 45% to 30% over the same time span.
Statistical analysis using adjusted odds ratios further emphasized the impact of delay.
For the youngest cohort, the AOR for a good outcome at ORT ≥300 minutes was significantly lower (0.085) compared to the earliest treatment window. While the association was "marginal" in the ≥80 age group, the overall trend confirms that delays negatively impact recovery across the lifespan.
Discussion
This study confirms that rapid reperfusion is beneficial for all stroke patients, including the very elderly. While the "ceiling" for recovery is lower in older patients—likely due to pre-existing comorbidities and frailty—the relative importance of speed remains. The findings suggest that age alone should not be a deterrent to rapid intervention. Future research should explore "biological age" markers, such as collateral flow or frailty scores, to further refine treatment windows for the elderly population.
Summary updated